Dynavax Technologies (DVAX) Short Interest Ratio & Short Volume → Dems have chosen Biden replacement? (From Paradigm Press) (Ad) Free DVAX Stock Alerts $11.74 +0.02 (+0.17%) (As of 05/3/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Dynavax Technologies Short Interest DataCurrent Short Volume18,540,000 sharesPrevious Short Volume17,970,000 sharesChange Vs. Previous Month+3.17%Dollar Volume Sold Short$216.73 millionShort Interest Ratio / Days to Cover9.6Last Record DateApril 15, 2024Outstanding Shares130,860,000 sharesPercentage of Shares Shorted14.17%Today's Trading Volume1,817,395 sharesAverage Trading Volume2,014,612 sharesToday's Volume Vs. Average90% Short Selling Dynavax Technologies ? Sign up to receive the latest short interest report for Dynavax Technologies and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatDVAX Short Interest Over TimeDVAX Days to Cover Over TimeDVAX Percentage of Float Shorted Over Time Ad Allegiance GoldCould Your Accounts Be Frozen?The US Dollar Is "Finished" A deteriorating economy, global instability, and a weakened banking system have pushed the U.S. financial system to the brink, imperiling the value of your savings and investments.Get your Free Wealth Protection Kit Dynavax Technologies Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/202418,540,000 shares $216.73 million +3.2%N/A9.6 $11.69 3/31/202417,970,000 shares $223.01 million +3.6%N/A9.2 $12.41 3/15/202417,350,000 shares $209.07 million +6.0%N/A8.9 $12.05 2/29/202416,370,000 shares $207.41 million +9.1%N/A8.6 $12.67 2/15/202415,000,000 shares $187.20 million +4.7%N/A8 $12.48 1/31/202414,330,000 shares $185.14 million -1.2%N/A8 $12.92 Get the Latest News and Ratings for DVAX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Dynavax Technologies and its competitors with MarketBeat's FREE daily newsletter. 1/15/202414,510,000 shares $202.12 million -2.9%13.9%8.1 $13.93 12/31/202314,950,000 shares $209.00 million +1.6%N/A9.1 $13.98 12/15/202314,710,000 shares $200.94 million +9.0%N/A9.2 $13.66 11/30/202313,490,000 shares $184.81 million -2.7%N/A8.8 $13.70 11/15/202313,860,000 shares $187.53 million -0.1%N/A9.1 $13.53 10/31/202313,870,000 shares $197.09 million +5.8%N/A9.2 $14.21 10/15/202313,110,000 shares $186.69 million -12.9%N/A8 $14.24 9/30/202315,050,000 shares $222.29 million +2.7%N/A9 $14.77 9/15/202314,660,000 shares $200.11 million +4.5%N/A8.4 $13.65 8/31/202314,030,000 shares $201.47 million -4.4%N/A7.7 $14.36 8/15/202314,670,000 shares $210.66 million -13.8%N/A8.2 $14.36 7/31/202317,020,000 shares $238.11 million -6.0%N/A9.5 $13.99 7/15/202318,110,000 shares $251.91 million -14.3%N/A11.6 $13.91 6/30/202321,140,000 shares $273.13 million +1.4%N/A14.3 $12.92 6/15/202320,840,000 shares $270.09 million +11.4%N/A15.7 $12.96 5/31/202318,700,000 shares $213.74 million +1.9%N/A15 $11.43 5/15/202318,360,000 shares $210.41 million +1.8%N/A13.2 $11.46 4/30/202318,040,000 shares $187.80 million -0.2%N/A13.1 $10.41 4/15/202318,070,000 shares $200.94 million -0.9%N/A12.8 $11.12 3/31/202318,230,000 shares $178.84 million +2.2%N/A12.6 $9.81 3/15/202317,840,000 shares $173.94 million +10.4%N/A12 $9.75 2/28/202316,160,000 shares $166.45 million -13.3%N/A10 $10.30 2/15/202318,640,000 shares $213.43 million +25.5%N/A11.7 $11.45 1/31/202314,850,000 shares $168.99 million +12.8%N/A9.1 $11.38 1/15/202313,170,000 shares $149.48 million +2.9%N/A7.5 $11.35 12/30/202212,800,000 shares $136.19 million -7.3%N/A7.2 $10.64 12/15/202213,800,000 shares $153.87 million -0.1%N/A7.4 $11.15 11/30/202213,820,000 shares $171.51 million -12.1%N/A7.4 $12.41 11/15/202215,730,000 shares $206.22 million +9.2%N/A8.5 $13.11 10/31/202214,400,000 shares $164.88 million -17.8%N/A6.8 $11.45 10/15/202217,520,000 shares $187.64 million +3.0%N/A8 $10.71 9/30/202217,010,000 shares $177.58 million +7.5%N/A8.2 $10.44 9/15/202215,830,000 shares $182.20 million +0.9%N/A7.7 $11.51 8/31/202215,690,000 shares $179.96 million -7.7%N/A7.5 $11.47Elon’s New Device is About to Shock the World (Ad)Using this device you see above… Elon Musk just tested a new type of A.I. that according to Wired Magazine will usher in… “The next step in human evolution.” Click here to see the details because there’s a lot of money at stake. DVAX Short Interest - Frequently Asked Questions What is Dynavax Technologies' current short interest? Short interest is the volume of Dynavax Technologies shares that have been sold short but have not yet been closed out or covered. As of April 15th, traders have sold 18,540,000 shares of DVAX short. Learn More on Dynavax Technologies' current short interest. What is a good short interest ratio for Dynavax Technologies? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. DVAX shares currently have a short interest ratio of 10.0. Learn More on Dynavax Technologies's short interest ratio. Is Dynavax Technologies' short interest increasing or decreasing? Dynavax Technologies saw a increase in short interest in the month of April. As of April 15th, there was short interest totaling 18,540,000 shares, an increase of 3.2% from the previous total of 17,970,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Dynavax Technologies' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Dynavax Technologies: Ligand Pharmaceuticals Incorporated (4.98%), Ironwood Pharmaceuticals, Inc. (13.96%), MannKind Co. (13.21%), Prothena Co. plc (12.34%), OPKO Health, Inc. (23.81%), Geron Co. (9.04%), Lexicon Pharmaceuticals, Inc. (8.17%), UroGen Pharma Ltd. (17.91%), Puma Biotechnology, Inc. (9.60%), G1 Therapeutics, Inc. (4.63%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Dynavax Technologies stock? Short selling DVAX is an investing strategy that aims to generate trading profit from Dynavax Technologies as its price is falling. DVAX shares are trading up $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Dynavax Technologies? A short squeeze for Dynavax Technologies occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of DVAX, which in turn drives the price of the stock up even further. How often is Dynavax Technologies' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including DVAX, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Ligand Pharmaceuticals Short Interest Data Ironwood Pharmaceuticals Short Interest Data MannKind Short Interest Data Prothena Short Interest Data OPKO Health Short Interest Data Geron Short Interest Data Lexicon Pharmaceuticals Short Interest Data UroGen Pharma Short Interest Data Puma Biotechnology Short Interest Data G1 Therapeutics Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:DVAX) was last updated on 5/3/2024 by MarketBeat.com Staff From Our PartnersElon to Transform U.S. Economy? Porter & CompanyBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldUrgent Nvidia WarningAltimetryAutomatic Income (from home)Awesomely, LLCCould Your Accounts Be Frozen?Allegiance GoldGold ManiaStansberry ResearchThe Gold Grab of the CenturyColonial MetalsThe A.I. story nobody is telling you (Read ASAP)TradeSmith